No Data
No Data
Leerink Partners Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Cuts Target Price to $21
Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI), Ardent Health Partners, Inc. (ARDT) and Doximity (DOCS)
Ardent Health Partners Is Maintained at Outperform by RBC Capital
RBC Capital Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Cuts Target Price to $21
RBC Capital Sticks to Their Buy Rating for Ardent Health Partners, Inc. (ARDT)
Express News | Ardent Health Partners Inc : Leerink Partners Cuts Target Price to $21 From $25